REPEAT — Pure Extracts Preparing Application for Dealers Licence
VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...
Year: 2020
Syneos Health Completes Acquisition of Synteract
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that...
Cerner Simplifies Ordering and Monitoring of Digital Health Solutions
Cerner teams with Xealth to foster digital innovation, strengthen connections between providers and patientsKANSAS CITY, Mo., Dec. 10, 2020 (GLOBE...
Entera Bio Announces FDA Approval of IND Application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis
EB613 Phase 2 Placebo-Controlled, Dose-Ranging Study Ongoing in Israel with Complete 3 Month Biomarker Data expected in Q1:21 and Final...
Bespoke Extracts to Sponsor Professional Mixed Martial Artist Cody Law in Bellator 254
MMA Pro Fighter Cody Law Sponsored by Bespoke Extracts. Bespoke Extracts Sponsors Pro MMA Fighter Cody Law in Bellator 254...
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting
-- Presentations highlight efficacy of TRV045 in animal models of neuropathic pain and epilepsy TRV045 selectively targets the S1P1 receptor...
Timber Pharmaceuticals Hosts Business Update Conference Call
Call to be held on Thursday, December 17th at 11:00am EST WOODCLIFF LAKE, N.J., Dec. 10, 2020 (GLOBE NEWSWIRE) --...
InvestorBrandNetwork (IBN) Coverage Initiated for CannAssist International Corp.
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC), a biotechnological pharmaceutical and...
Monopar and NorthStar Announce Selection of uPRIT Candidate for Potential Treatment of Severe COVID-19
WILMETTE, Ill. and BELOIT, Wis., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes,...
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line
WINNIPEG, Manitoba, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comBASKING RIDGE,...
AgraFlora Provides Guidance and Grow Update for its Delta Greenhouse
Picture 1 Delta, BC. AgraFlora Greenhouse VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or...
Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical...
Quotient Limited Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market
JERSEY, Channel Islands, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced...
James S. Shannon Transitions to Chairman of the Board of Directors for MannKind
Kent Kresa, former Chairman, will continue to serve as a DirectorWESTLAKE VILLAGE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- MannKind...
SCYNEXIS Announces Advancement of Ibrexafungerp’s Intravenous Formulation to Clinical Stage and Provides Further Updates on its Clinical Studies in Patients with Life-Threatening Fungal Infections
Approval granted by health authority for the intravenous (IV) formulation of ibrexafungerp to enter Phase 1; dosing in healthy volunteers...
X4 Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for Mavorixafor for the Treatment of WHIM Syndrome
BOSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial
Company Expects Interim Data in Mid-2021SAN DIEGO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical...
Tabula Rasa HealthCare Signs Agreement with Missouri Pharmacy Association to Provide Medication Safety Technology Education to Members
Association members will have the opportunity to become Certified MedWise Advisors™ creating a State-Wide Network to support Value-Based Payer AgreementsMOORESTOWN,...
Acquisition Agreement with Boehringer Ingelheim for NBE-Therapeutics Marks First Major Biotech Exit for PPF Group
€1.18 billion acquisition provides for significant returns to PPF Group as NBE’s largest shareholderSOTIO, a clinical stage immuno-oncology company, and...